CMS communication for waived Covid testing devices

14 followers
2 Likes

Have y'all seen this? It looks like our waived EUA devices won't be able to test asymptomatic patients unless it's allowed in the IFU. Not sure how this will affect our operations at this point, but I wish they had saved this for a later time!
Attachment.
CMS.png


18 Replies

THANK YOU
And Oh Dear!

No, but thank you!!  I had to go look at my IFU again lol.  Thank goodness it doesn't specify symptoms.

Thanks for sharing this Kathleen!  So the Sofia and Abbott IDnow both recommend serially testing for asymptomatic patients, are the labs responsible/considered noncompliant if the patient does not return within the expected window for the retest?

Attachment.
image.png
This is most certainly going to require some conversation.

I  cannot find this CMS memo online.  Where did you get this?  Game changer for some instruments.

QSO-22-25-CLIA (1).pdf
Here's the document from CMS

This looks like it includes all molecular and antigen testing for Covid on asymptomatic patients, waived or non-waived.  Am I reading that correctly?  If so this could pose an issue for our entire lab, not just POC

If they are in existence because of an Emergensy Use Authorization- you are correct.  All labs will be affected, unless the test has been put in place as laboratory developed. 

Basically, it's saying that we need to follow the manufacturer's instructions for use, including patient type, for our waived devices at POCT. For the lab, if the test is being used outside of IFU, then it would be high complexity, so could only be run in a high complexity lab that has done a complete validation, including validating asymptomatic patients. For our sites, we're good with the labs as we did a validation and they are mostly high complexity labs (doing transfusion medicine). For POCT, we do have devices at sites doing pre-procedure, pre-op testing, so we'll need to stop that. As Rosann Rosannadanna says "It's always something". 

Kathy 
Thank you so much for relaying this information to the group!  The directive states we have 30 days from issuance to come into compliance.
Our incident command convened today to discuss the ramifications:
  • Patients sent to LTR/DTR require a negative COVID test - per State Regulations??
  • Current RI Regulation for HCW with an exposure having serial testing
  • Preprocedural testing for Overnight Surgical Procedures
  • Testing on patient admitted through the Emergency Department.
Updated algorithms would be very helpful as we have a limited window to make these changes.

Hi everyone,

Has anyone found a EAU POC waived antigen test that can be performed on asymptomatic patients without also requiring serial testing?

Like many of you, the CMS memo is throwing a wrench in our current processes.

Thanks,

EDIT: well i think i found the answer to my own question. Answer is no according to fda list of ag tests.
In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2 | FDA


Stephen,

Looks like there are two on this list:
At-Home OTC COVID-19 Diagnostic Tests | FDA

Today's latest!! What is happening??
Attachment.
image.png

Someone sent this to me as well. We think it's related to rescinding the earlier document that allowed testing asymptomatic patients, meaning outside of the IFU. I'm not going to do anything on this until any further information.

Displaying items 1-15 of 18 in total
Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Kathleen David
almost 2 years ago
18
Replies
2
Likes
14
Followers
626
Views
Liked By:
Suggested Posts
TopicRepliesLikesViewsParticipantsLast Reply
Emergent in-home patient visits and POCT
sarah ganje
about 15 hours ago
0045
sarah ganje
Lancet expiration dates for glucose meter users
Pam Gadsby
about 17 hours ago
80176
Pam Gadsby
about 16 hours ago
Competency tracking program
Lindsey Sauer
2 days ago
50289
Lindsey Sauer
1 day ago